Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. (Q39905542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Carlo Gaetano

1 reference

ORCID Public Data File 2021

author name string

C Gaetano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

I S Goping

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D N Brindley

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

15 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1028-1039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079345%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2008.442

18 January 2020

exact match

0 references

cites work

Serum lysophosphatidic acid is produced through diverse phospholipase pathways

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

A 5' Leader of Rbm3, a Cold Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased Efficiency under Conditions of Mild Hypothermia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Taxol-induced ceramide generation and apoptosis in human breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Human intestinal epithelial cell survival and anoikis. Differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Phosphodiesterase-I alpha/autotaxin controls cytoskeletal organization and FAK phosphorylation during myelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Human intestinal epithelial cell survival: differentiation state-specific control mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl‐2 homologs by Fak, PI3‐K/Akt‐1, MEK/Erk, and p38 signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

31 March 2020

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Prognostic significance of apoptosis regulators in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Weekly administration of paclitaxel: theoretical and clinical basis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Apoptotic pathways in tumor progression and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

The emerging role of lysophosphatidic acid in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

The ins and outs of lysophosphatidic acid signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Sphingolipids in neuroblastoma: their role in drug resistance mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Rational combinations of siRNAs targeting Plk1 with breast cancer drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Molecular mechanisms of lysophosphatidic acid action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Lysophosphatidic acid as a novel cell survival/apoptotic factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442

Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.442